1998
DOI: 10.1016/s0264-410x(98)80102-3
|View full text |Cite
|
Sign up to set email alerts
|

Vaccination against tick-borne encephalitis virus, a flavivirus, prevents disease but not infection, although viremia is undetectable

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
12
0
2

Year Published

2000
2000
2019
2019

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 22 publications
(14 citation statements)
references
References 17 publications
0
12
0
2
Order By: Relevance
“…Neutralizing antibodies are long-lasting following natural infection and protection against disease on re-exposure is complete, although re-exposure often is accompanied by a boost in antibody indicating limited infection. Studies employing passive transfer of polyclonal immune serum or monoclonal antibodies to Japanese encephalitis (JE) (10, 2628), West Nile (WN) (16, 2931), tick-borne encephalitis (TBE) (32–35) and YF (36,37) demonstrated that nAbs against the envelope protein confers protective immunity against virus challenge.…”
Section: Discussionmentioning
confidence: 99%
“…Neutralizing antibodies are long-lasting following natural infection and protection against disease on re-exposure is complete, although re-exposure often is accompanied by a boost in antibody indicating limited infection. Studies employing passive transfer of polyclonal immune serum or monoclonal antibodies to Japanese encephalitis (JE) (10, 2628), West Nile (WN) (16, 2931), tick-borne encephalitis (TBE) (32–35) and YF (36,37) demonstrated that nAbs against the envelope protein confers protective immunity against virus challenge.…”
Section: Discussionmentioning
confidence: 99%
“…Cross-reactions due to family-wide envelope protein epitopes may occur when classic techniques such as hemagglutination-inhibition (HI), complement fixation (CF) and immunofluorescence [8][9][10] are used. For example, individuals vaccinated against yellow fever have yielded false-positive results in HI tests or in a commercially produced enzyme-linked immunosorbent assay (ELISA) for antibody to tickborne encephalitis (Immuno AG, Vienna, Austria; unavailable in the United States).…”
Section: Introductionmentioning
confidence: 99%
“…Так, в исследовании T.R. Kreil et al [33] мышей вна-чале иммунизировали вакциной FSME-Immune (по схеме, трижды) и затем заражали летальной дозой ВКЭ. Как и ожидалось, после иммуни-зации индуцировались высокие титры антител против белка E, что приводило к 100% выжива-емости.…”
Section: крылова нв Medical Immunology (Russia)/meditsinskaya Immununclassified